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Abstract: 
Background:  
Mindfulness-based interventions (MBIs) have been increasingly used as an 
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adjunctive treatment to pharmacotherapy for a few psychiatric disorders. 
However, few studies have investigated the efficacy of MBIs in bipolar disorder 
(BD).  
Methods:  
We performed a systematic review and meta-analysis to evaluate the efficacy 
of MBIs as an adjunctive treatment in BD. Major electronic databases were 
independently searched by two authors for controlled and uncontrolled studies 
which examined the effects of MBIs on psychiatric symptoms in subjects with BD. 
Data from original studies were synthesized by using a random effects model. 
Results:  
Twelve trials were eligible for inclusion into current meta-analysis, including 
three controlled studies (n=132) and nine uncontrolled studies (n=142). In 
within-group analysis, MBIs significantly reduced depressive (7 studies, n=100, 
Hedges’ g=0.58, p<0.001) and anxiety (4 studies, n=68, Hedges’ g=0.34, p=0.043) 
symptoms, but not manic symptoms (6 studies, n=89, Hedges’ g=0.09, p=0.488) 
and cognition (3 studies, n=43, Hedges’ g=0.35, p=0.171), compared to baseline. 
In between-group analysis (intervention group versus waiting list group, all 
patients with BD), MBIs did not reduce depressive (3 studies, n=132, Hedges’ 
g=0.46, p=0.315) or anxiety (3 studies, n=132, Hedges’ g=0.33, p=0.578) 
symptoms.  
Limitations:  
Only three controlled trials compared MBIs to control conditions. 
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Conclusions:  
Our meta-analysis showed significantly beneficial effects on depressive and 
anxiety symptoms of BD patients in within-group analysis. However, this 
significance was not observed in comparison with the control groups. Further 
clinical trials are warranted to investigate the differences in the benefits of MBIs 
between treatment and control subjects. 
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Abbreviation list 
BAI: Beck anxiety index; BD: bipolar disorder; BDI: Beck depression inventory; CPAS: 
clinical positive affective scale; DASS: depression anxiety stress scales; DSM-IV: 
diagnostic and statistical manual of mental disorders, 4th edition; FFMQ: five-facet 
mindfulness questionnaire; HADS: hospital anxiety and depression scale; HAMD: 
Hamilton depressive scale; KIMS: Kentucky inventory of mindfulness skills, MAAS: 
mindful attention awareness scale; MADRS: Montgomery–Åsberg depression rating 
scale; MBI: mindfulness-based intervention; n/a: not available; Pre-post Tx: 
comparison of disease severity before and after treatment; STAI: state-trait anxiety 
inventory; TAU: treatment as usual; Tx: treatment; YMRS: Young mania rating scale 
 
Introduction 
The global prevalence of bipolar disorder (BD) in primary care is 1.8% (Stubbs et 
al., 2016), and it is one of the leading causes of disability worldwide (Garland et al., 
2016). BD is characterized primarily by recurring affective episodes of depression, 
(hypo)mania and mixed states. In addition, patients with BD often have impaired 
psychosocial functions, even when in remission (Garland et al., 2016). Even after 
drug treatment, up to 48.5% of patients with BD have been reported to experience 
relapses and/or recurrence of major affective episodes within a 2-year follow-up 
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period (Perlis et al., 2006). Furthermore, even if these patients improve after acute 
episodes, pervasive depressive symptoms remain (Judd et al., 2003) in addition to 
the cognitive symptom of emotional regulation disability (Gruber, 2011). Several 
psychosocial interventions including interpersonal therapy, family therapy, and 
cognitive-behavioral therapy have been developed as adjunctive therapy to treat BD 
(Grande et al., 2016). Among these psychosocial interventions, psychoeducation, 
interpersonal therapy, family therapy, non-mindfulness based cognitive-behavioral 
therapy, and systematic care have been proven to be effective in preventing relapses, 
stabilizing episodes, and reducing episode length (Miklowitz, 2008; Miziou et al., 
2015; Oud et al., 2016). For example, a recent meta-analysis by Oud et al reported 
that individual psychological interventions could reduce the severity of depressive 
but not manic symptoms (standardized mean difference [SMD] = -0.23, 95% 
confidence interval [CI] = -0.41 to 0.05; SMD = -0.05, 95% CI = -0.35 to 0.25, 
respectively). Another study also suggested that these non-medical therapies could 
help in ameliorating core inter-episode symptoms (Opialla et al., 2015).  
Recently, interest has grown in the potential of mindfulness-based interventions 
(MBIs) to improve outcomes of patients with psychiatric illnesses. MBIs are based on 
the premise of paying total attention on purpose in the present moment and 
non-judgmental attention to inner and outer experiences moment by moment 
(Kabat-Zinn, 1994). MBIs were first developed by Kabat-Zinn as mindfulness-based 
stress reduction (MBSR) in the 1970s to enhance the stress coping skills of patients 
with chronic pain (Kabat-Zinn, 1990). Later, MBIs were used as the core of 
mindfulness-based cognitive therapy (MBCT) by combining elements of MBSR and 
cognitive therapy in order to prevent relapses/recurrence of unipolar depressive 
episodes (Teasdale et al., 1995; Teasdale et al., 2000). For example, a recent 
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meta-analysis which synthesized available evidence from 1,329 participants found 
that MBCT reduced depressive relapse rates within a 60-week follow-up period 
compared to participants who did not receive MBCT (Kuyken et al., 2016). Another 
meta-analysis suggested that MBIs could also be effective as an adjunctive treatment 
for negative symptoms among patients with psychosis (Khoury et al., 2013).  
However, relatively few studies have investigated the effect of MBIs on 
treatment outcomes in patients with BD. Uncontrolled (Biseul et al., 2016; Bos et al., 
2014; Crane et al., 2008; Deckersbach et al., 2012; Howells et al., 2014; Miklowitz et 
al., 2009; Miklowitz et al., 2015; Murray et al., 2015; Perich et al., 2013a; Stange et al., 
2011; Weber et al., 2010) and controlled trials (Ives-Deliperi et al., 2013; Perich et al., 
2013b; Van Dijk et al., 2013; Williams et al., 2008) have shown that the combination 
of MBIs with pharmacotherapy and treatment as usual (TAU) can have beneficial 
effects for patients with BD. Furthermore, a previous functional magnetic resonance 
imaging study showed the potential involvement and beneficial effects of MBIs in 
specific neural circuits underlying emotional regulation (Opialla et al., 2015), which is 
one of the main core inter-episode symptoms in BD (Gruber, 2011). Conversely, 
other studies have found no significant effect of MBIs on depressive (Howells et al., 
2014; Ives-Deliperi et al., 2013; Perich et al., 2013b; Weber et al., 2010), manic 
(Deckersbach et al., 2012; Perich et al., 2013b), or anxiety (Howells et al., 2014) 
symptoms. 
These inconsistencies may be due to the small sample size in most studies (Crane 
et al., 2008; Deckersbach et al., 2012; Miklowitz et al., 2009; Murray et al., 2015; 
Perich et al., 2013a; Stange et al., 2011; Van Dijk et al., 2013; Williams et al., 2008), 
lack of standardized outcome measurement, different intervention characteristics 
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(e.g. study duration varying from 3 to 12 weeks of MBCT training), different 
characteristics of the participants (Bos et al., 2014; Weber et al., 2010; Williams et al., 
2008), high attrition rates early in the study (Bos et al., 2014; Murray et al., 2015), 
and disparate study designs (Bos et al., 2014; Howells et al., 2014; Murray et al., 2015; 
Van Dijk et al., 2013). In addition, the absence of a comparison treatment control 
group in many studies makes the findings less robust when considered in isolation 
(Bos et al., 2014; Crane et al., 2008; Deckersbach et al., 2012; Miklowitz et al., 2009; 
Murray et al., 2015; Stange et al., 2011; Weber et al., 2010).  
Two meta-analyses investigating MBIs in patients with mental disorders have 
previously been conducted with mixed groups of patients with mood or anxiety 
disorders (Chiesa and Serretti, 2011; Hofmann et al., 2010). Whilst helpful, the 
generic focus, the fact that only two trials involving participants with BD were 
included, and failure to consider core symptoms of BD such as mania (Chiesa and 
Serretti, 2011), limits the conclusions regarding the efficacy of MBIs in patients with 
BD. More recently, several uncontrolled clinical trials examined the effectiveness of 
MBIs in patients with BD (Biseul et al., 2016; Bos et al., 2014; Miklowitz et al., 2015; 
Murray et al., 2015), however no dedicated systematic review and meta-analysis has 
investigated the use of MBIs as treatment for BD.  
Given these limitations and gaps in the literature, we conducted this 
comprehensive systematic review and meta-analysis to investigate the role of MBIs 
as an adjunctive therapy for patients with BD.  
Method and Materials 
The current systematic review and meta-analysis was conducted in line with the 
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PRISMA guidelines (Liberati et al., 2009) (Supplement Table 1 and Supplement Figure 
1). 
 
Eligibility criteria 
In order to be eligible for inclusion, articles had to meet the following criteria: (1) 
peer-reviewed original articles investigating the adjunctive effect of MBIs in patients 
with BD compared to a control group (controlled studies) or without a control group 
(uncontrolled studies); (2) a diagnosis of BD based on either DSM-IV (Association, 
1994) or ICD (Diseases) code; (3) used MBIs (including MBSR, MBCT, and other 
interventions in which mindfulness represented a core component); and (4) articles 
written in English.  
We excluded non-clinical trials articles from the present study (e.g. case series, 
observational studies). We also excluded studies investigating mixed populations of 
patients (e.g. both patients with BD and major depression joined), unless the articles 
provided separated data for those with BD and major depression. In addition, we 
excluded studies that examined mindfulness as part of another treatment modality 
as it would have been difficult to differentiate the treatment effect of mindfulness 
from other components (Khoury et al., 2013). Therefore, we excluded studies on 
dialectical behavior therapy and acceptance and commitment therapy. We also 
excluded studies with a short duration (< 3 weeks) and those on self-help 
interventions such as online MBIs (Murray et al., 2015)  
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Database searches and study selection 
Two authors (CS Chu and PT Tseng) independently searched PubMed, 
ScienceDirect, EBSCOhost-Medline, Psychology and Behavior Sciences Collection, 
Cochrane library, and ClinicalTrials.gov from inception until November 28, 2016 using 
the following search terms: (mindfulness OR meditation) AND (bipolar OR bipolar 
disorder). A filter of “patient/treatment/mental 
health/depression/sleep/eeg/ptsd/anxiety/mental/bipolar 
disorder/participant/adhd/bipolar/anxiety disorder/emotion regulation/journal” 
were done on the platform of ScienceDirect (http://www.sciencedirect.com). 
Furthermore, potentially relevant studies were also identified from the reference lists 
of the included studies, reviews, and meta-analyses of interventions that used MBIs 
as adjunctive therapy to treat patients with BD (Chiesa and Serretti, 2011; Marchand, 
2012; Mehrmann and Karmacharya, 2013; Sipe and Eisendrath, 2012).  
Duplicates were removed from the total number of identified records. 
Abstracts from the remaining records were then screened to retrieve full-text articles 
to assess their eligibility. Full details of the search strategy are shown in Figure 1.  
Following the database search, two authors independently screened the titles 
and abstracts of the search results to assess whether they met the inclusion criteria. 
The two authors selected a list of studies that met the eligibility criteria to be 
considered at the full text review. Any inconsistencies were resolved by consensus. 
 
Methodological quality appraisal 
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Two independent authors rated the quality of the included articles using the 
Jadad scale (Jadad et al., 1996). The Jadad scale consists of a three-point 
questionnaire to assess the study with regards to it being randomized, double-blind, 
and whether it included a description of withdrawals and dropouts. Each question 
was answered with either yes or no, with a total score ranging from zero (poor 
quality) to five (high quality) (Supplementary Table 3). 
 
Primary outcomes 
The primary outcome was changes in scores from baseline to post-treatment in 
forms of standard rating scales assessing depressive, anxiety and manic symptoms. 
The primary outcome was analyzed from 12 articles, four of them provided 
relevant data of intent-to-treat analysis (Bos et al., 2014; Deckersbach et al., 2012; 
Miklowitz et al., 2015; Perich et al., 2013b).  
 
Secondary outcomes 
The secondary outcomes included the effect of MBIs on cognition, stress, 
emotional regulation, and mindfulness ability. In addition, we assessed the effect of 
MBIs on cognitive subdomains including attention, cognitive flexibility, executive, 
impulsiveness/distractibility, and spatial/verbal memory. 
 
Data extraction and management 
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Two independent authors extracted data for the meta-analysis using a 
pre-specified data extraction form. These data included mean age, female gender, 
marriage, occupation, age at disease onset, disengagement early from the study, 
combined with other psychotherapy, and the use of alcohol/illicit drugs. Other 
variables related to MBIs included duration of mindfulness treatment, total number 
of sessions and duration of each session. 
We also extracted data on the levels of depressive/manic symptoms/cognitive 
impairment according to the most commonly used scales in the included studies. The 
Beck depression inventory (BDI) was the most frequently used scale to assess 
depressive mood, followed by the depression anxiety stress scale (DASS) and 
Montgomery-Åsberg depression rating scale (MADRS). Therefore, we extracted the 
BDI scores of the participants with depression first, and then those of the DASS and 
MADRS. For anxiety, the scales were Beck anxiety index, DASS, and state-trait anxiety 
inventory (STAI), and for mania, the Young mania rating scale (YMRS). When data 
were not available in the articles, we attempted to contact the authors to ask for 
access to the data on at least two separate occasions.  
Meta-analysis 
The analyses included both controlled and uncontrolled studies for 
between-group analysis and within-group analysis, respectively. All meta-analytic 
procedures were performed using Comprehensive Meta-Analysis software, version 2 
(Biostat, Englewood, NJ). For the primary and secondary outcomes, we calculated 
Hedges’ g statistic as the estimate of within-group effect size (ES; and 95% 
confidence intervals (CIs)) for changes from pre-treatment to post-treatment and 
between-group (intervention group versus control group) effect size for each 
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outcome (depressive symptoms, anxiety, mania, stress, emotional regulation, 
cognition, and mindfulness ability). The Hedges’ g statistic provides a relatively 
unbiased standardized ES estimate (Hedges and Olkin, 1985). We calculated the 
Hedges’ g statistic with 95% CIs to compare the effect of MBIs in the controlled 
studies only. The Hedges’ g statistics for the primary and secondary outcomes were 
calculated based on changes from baseline to post-test. Some studies provide 
follow-up data (at 1, 3, 6, and 12 months after the MBIs), but we did not analysis 
these data in the present study (Deckersbach et al., 2012; Miklowitz et al., 2015; 
Perich et al., 2013a; Perich et al., 2013b; Stange et al., 2011; Weber et al., 2010). 
We next calculated the Hedges’ g from baseline to post-treatment for MBIs 
across secondary outcomes including cognition scores and subdomains. In addition, 
where possible we performed subgroup meta-analysis if data from three or more 
enrolled studies were available. If Hedges’ g could not be derived from the raw 
scores of each rating scale, we tried to derive Hedges’ g from other statistical 
parameters such as the t or p value considering the sample size. Due to the 
anticipated heterogeneity, we employed a random-effects model for every 
meta-analysis in the current study. Subgroup analyses were conducted separating 
the included studies into uncontrolled and controlled studies. 
We set statistical significance as two-tailed P values less than 0.05. We used the 
I2 statistic and Cochran's Q test to examine heterogeneity across the included studies 
(Higgins et al., 2003). Heterogeneity was considered large when the p value of the Q 
test was less than 0.05. Publication bias was assessed through the visual inspection 
of funnel plots and with Egger’s regression test (Egger et al., 1997). In addition, to 
investigate the possible confounding effects of clinical variables, we conducted 
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meta-regression and subgroup meta-analyses. The meta-regression procedure was 
performed with an unrestricted maximum likelihood method only if five studies were 
available, and subgroup meta-analysis was performed when at least three sets of 
data were available. 
In secondary analyses, we examined whether particular subgroups of patients 
benefited from MBIs. We performed meta-regression analysis with the variables of 
interest when data were available from five or more of the recruited studies. The 
clinical variables entered into the meta-regression analysis included age, gender, 
disengagement early from the study, treatment duration of mindfulness, and Jadad 
scores. 
 
Results 
Studies included in the meta-analysis 
After excluding five studies with mixed populations of patients (e.g. both 
patients with BD and major depression joined together) (Crane et al., 2008; Garland 
et al., 2016; Hamilton et al., 2012; Kenny and Williams, 2007; Ramel et al., 2004)(full 
details in Figure 1 and Supplementary Table 2), 12 articles met the inclusion criteria 
(Biseul et al., 2016; Bos et al., 2014; Deckersbach et al., 2012; Howells et al., 2014; 
Ives-Deliperi et al., 2013; Miklowitz et al., 2009; Miklowitz et al., 2015; Perich et al., 
2013a; Perich et al., 2013b; Stange et al., 2011; Weber et al., 2010; Williams et al., 
2008) (Table 1). The enrolled studies included 274 participants (68.5% female), with a 
mean age of 41.1 (standard deviation (SD)=10.7) years. 
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Among the recruited 12 articles, the study by Perich (2013a) was designed as 
randomized comparison trial but both of the groups received MBIs with different 
frequency (Perich et al., 2013a). Three of the included articles were controlled trials 
and included 132 participants (mean age = 39.2 (SD 10.3) years, mean proportion of 
females = 56.2%) (Ives-Deliperi et al., 2013; Perich et al., 2013b; Williams et al., 2008). 
The remaining nine studies were uncontrolled studies and included 142 participants 
(mean age = 41.8 (SD=10.8) years, mean proportion of females = 73.7%) (Biseul et al., 
2016; Bos et al., 2014; Deckersbach et al., 2012; Howells et al., 2014; Miklowitz et al., 
2009; Miklowitz et al., 2015; Perich et al., 2013a; Stange et al., 2011; Weber et al., 
2010). The baseline mood characteristics of the participants in these selected studies 
were euthymic (defined as a HADS score < 10 and YMRS score <4) (Howells et al., 
2014), in remission (defined as meeting the DSM-IV-TR or National Institute of 
Mental Health (NIMH) criteria) (Miklowitz et al., 2009; Williams et al., 2008), or 
residual depressive or manic symptoms (Biseul et al., 2016; Deckersbach et al., 2012; 
Ives-Deliperi et al., 2013; Miklowitz et al., 2015; Perich et al., 2013a; Perich et al., 
2013b; Stange et al., 2011; Weber et al., 2010) (Supplementary Table 5).  
All twelve trials compared changes in the severity of depressive, anxiety, and 
manic symptoms after MBIs. Of them, 10 used MBCT (Deckersbach et al., 2012; 
Howells et al., 2014; Ives-Deliperi et al., 2013; Miklowitz et al., 2009; Miklowitz et al., 
2015; Perich et al., 2013a; Perich et al., 2013b; Stange et al., 2011; Weber et al., 2010; 
Williams et al., 2008), one used mindfulness-based relapse prevention (MBRP) 
(Biseul et al., 2016), and one used mindfulness training (Bos et al., 2014). The 
duration of mindfulness therapy in these studies was 8 (Biseul et al., 2016; Bos et al., 
2014; Howells et al., 2014; Ives-Deliperi et al., 2013; Miklowitz et al., 2009; Miklowitz 
et al., 2015; Perich et al., 2013a; Perich et al., 2013b; Weber et al., 2010; Williams et 
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al., 2008) or 12 weeks (Deckersbach et al., 2012; Stange et al., 2011). Six of the 
studies provided follow-up data (at 1, 3, 6, and 12 months after the MBIs) 
(Deckersbach et al., 2012; Miklowitz et al., 2015; Perich et al., 2013a; Perich et al., 
2013b; Stange et al., 2011; Weber et al., 2010). In this meta-analysis, we used the 
post-treatment outcome data immediately after the interventions (except for one 
study which defined re-assessment within 1 week (Weber et al., 2010) and another 
which defined re-assessment within 1 month (Stange et al., 2011) after the 
interventions). 
Methodological quality of the included studies 
Similar to previous systematic reviews and meta-analyses of MBCT (Chiesa and 
Serretti, 2011; Coelho et al., 2007), we assessed the quality of the included studies 
using the Jadad scale. Across all 12 studies, the average Jadad score was 1.33 with a 
SD of 0.49 (Supplement Table 3). The average Jadad score in the controlled studies 
was 1.67 (SD = 0.58) compared to 1.11 (SD = 0.33) in the uncontrolled studies. 
 
Meta-analysis investigating the effect of mindfulness-based interventions on the 
symptom load: pre- to post-test studies  
For symptom load in pre- to post-test studies, MBIs resulted in significant 
improvements in depressive and anxiety symptoms after the intervention (depressive, 
k = 7, n = 100, Hedges’ g = 0.58, 95% CI = 0.31-0.84, p < 0.001; anxiety, k = 4, n = 68, 
Hedges’ g = 0.34, 95% CI = 0.01-0.67, p = 0.043) (Figure 2A and 2B). This significance 
persisted when focusing on the studies using MBCT only (depressive, k = 6, n = 95, 
Hedges’ g = 0.59, 95% CI = 0.29-0.90, p< 0.001; anxiety, k = 4, n = 68, Hedges’ g = 
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0.34, 95% CI = 0.01-0.67, p= 0.043). Only one study provided data on changes in 
depressive symptoms but not anxiety symptoms in patients receiving treatment 
other than MBCT (they used MBRP), and this study was not included in subgroup 
meta-analysis (Biseul et al., 2016). In that study, the main changes in depressive 
symptoms also showed a significant improvement (MADRS from 14.3 +/-11.3 to 4.5 
+/- 2.3) (Biseul et al., 2016). However, MBIs did not significantly improve manic 
symptoms (k = 6, n = 89, Hedges’ g = 0.09, 95% CI = -0.16-0.33, p = 0.488) (Figure 2C). 
In addition, this insignificance persisted after focusing on the studies using MBCT (k = 
5, n = 84, Hedges’ g = 0.06, 95% CI = -0.20-0.31, p = 0.662). As above, only the study 
by Biseul provided data on changes in manic symptoms with treatment other than 
MBCT (they used MBRP) (Biseul et al., 2016), and subgroup meta-analysis was not 
performed. The main changes in manic symptoms in Biseul`s study did not achieve 
statistical significance (YMRS from 1.2 +/- 1.3 to 0.3 +/- 0.8) (Biseul et al., 2016). 
There was no evidence of significant publication bias in Egger’s regression test 
with regards to depression and anxiety but significant publication bias was found in 
manic symptoms (depressive, t value = 0.31, df = 5, p = 0.77; anxiety, t value = 0.56, 
df = 2, p = 0.630; mania, t value = 4.15, df = 4, p = 0.014) or heterogeneity 
(depressive, Q value = 5.62, df = 6, I2 = 0.00, p = 0.467; anxiety, Q value = 1.26, df = 3, 
I2 = 0.00, p = 0.738; mania, Q value = 1.56, df = 5, I2 = 0.00, p = 0.906). 
The meta-analysis results for the primary outcomes are shown in Figure 2. 
 
Meta-analysis of investigating of the effect of mindfulness-based interventions on 
symptom load: controlled trials  
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For symptom load in the controlled studies, MBIs were not significantly more 
efficacious than control conditions in improving depressive and anxiety symptoms 
(depressive, k = 3, n = 132, Hedges’ g = 0.46, 95% CI = -0.44-1.35, p = 0.315; anxiety, k 
= 3, n = 132, Hedges’ g = 0.33, 95% CI = -0.84-1.50, p = 0.578) (Figure 3A and 3B). For 
mania, only one study compared MBIs with TAU, and no significant treatment effect 
was observed (n = 95, baseline YMRS scores MBIs: 4.98 +/- 4.49, Controls: 5.47 +/- 
4.36; post-treatment, MBIs: 3.97 +/- 4.57, Controls: 4.44 +/- 4.38, non-significance). 
There was no evidence of publication bias in Egger’s regression test (depressive, 
t value = 6.43, df = 1, p = 0.098; anxiety, t value = 4.29, df = 1, p = 0.146). However, 
significant heterogeneity was observed both in anxiety symptoms and depressive 
symptoms (depressive, Q value = 8.07, df = 2, I2 = 75.2, p = 0.018; anxiety, Q value = 
13.6, df = 2, I2 = 85.3, p = 0.001). 
 
Meta-regression of MBIs symptom load moderators 
No other significant associations were found between the various outcomes 
(i.e. depression and anxiety) and covariates in the uncontrolled studies (supplement 
table 4). 
 
Meta-analysis: the effect of mindfulness-based interventions on secondary 
outcomes 
For the secondary outcomes, comparing changes in baseline to 
post-treatment scores, MBIs significantly improved mindfulness ability (k = 5, n = 81, 
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Hedges’ g = 0.49, 95% CI: 0.12-0.85, p = 0.009) and attention (k = 3, n = 43, Hedges’ g 
= 0.61, 95% CI: 0.19-1.03, p = 0.005) in patients with BD, but not in cognition (k = 3, n 
= 43, Hedges’ g = 0.35, 95% CI: -0.15-0.84, p = 0.171) (Figure 4A to 4C, scale used in 
Supplementary Table 5). We could not perform subgroup meta-analyses in the other 
subdomains of cognition and stress as there were fewer than three relevant articles 
for each. However, MBIs seemed to improve executive and spatial/verbal memory 
rather than cognitive flexibility and impulsiveness/distractibility in two trials 
(Ives-Deliperi et al., 2013; Stange et al., 2011). With regards to the prevention of 
relapse/recurrence, only two studies (one uncontrolled and one controlled study) 
considered this as a secondary outcome (Miklowitz et al., 2015; Perich et al., 2013b). 
Therefore, we could not perform meta-analysis on these data. 
 
 Adverse events and attrition 
     Although we tried to investigate potential adverse events associated with the 
MBIs, none of the enrolled studies reported any adverse event during treatment. 
Regarding attrition, the rate ranged from 8.2% (Biseul et al., 2016) to 41.7% 
(Miklowitz et al., 2015). Two studies reported that all participants completed the 
whole study (Howells et al., 2014; Ives-Deliperi et al., 2013) and another two did not 
provide data (Bos et al., 2014; Williams et al., 2008). 
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Discussion 
The results of this current meta-analysis indicate that patients with BD may 
experience significant improvements in depressive and anxiety symptoms but not 
manic symptoms after receiving MBIs, according to endpoint versus baseline severity 
scores. However, these apparently beneficial effects were derived from uncontrolled 
trials (pre- to post-test studies), whilst in the few (k=3) included controlled trials, 
MBIs failed to significantly improve the severity of depressive, anxiety, or manic 
symptoms. For the secondary outcomes, MBIs seemed to improve attention and 
mindfulness ability and attention in the patients with BD, again in pre- to post-test 
analyses. Nevertheless, there were insufficient data to compare MBIs to control 
conditions for our secondary outcome measures. 
To the best of our knowledge, this is the first meta-analysis to specifically focus 
on the efficacy of adjunctive MBIs in patients with BD and to comprehensively assess 
distinct outcomes with regards to the symptoms of BD. Overall, the within-group 
effect sizes were moderate for depressive (0.58) and small for anxiety (0.34), 
however they were negligible in between-groups analyses. A comprehensive 
comparison of the main results of the current meta-analysis and previous 
meta-analyses is summarized in Table 2 (Chiesa and Serretti, 2011; Gotink et al., 2015; 
Hofmann et al., 2010; Klainin-Yobas et al., 2012; Kuyken et al., 2016; Piet and 
Hougaard, 2011; Strauss et al., 2014), which showed that our results are consistent 
with previous reports with regards to the effects of MBIs in the treatment of 
depressive mood in patients with mental disorders (Chiesa and Serretti, 2011; 
Klainin-Yobas et al., 2012; Strauss et al., 2014). Similarly, we found significant 
differences in the severity of anxiety in the pre- and post- analyses. These findings 
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were all derived from uncontrolled trials, and therefore there is currently a lack of 
strong evidence supporting the role of MBIs in patients with BD in clinical practice. 
More controlled studies are needed to better determine the effect of MBIs on mood 
severity. In particular, future randomized controlled trials (RCTs) are needed to 
compare the influence of MBIs versus control conditions to rule out a potential 
non-specific effect in the pre- and post-test analyses. In the three RCTs in our analysis 
we found no effect on the primary outcomes. The effect size is quite substantial 
(Hedges’ g=0.46 and 0.33 for reducing depression and anxiety, respectively), but 
the p-value is not significant because of the small sample sizes of three RCTs. 
However, three studies are clearly insufficient to make any strong recommendations 
regarding the potential efficacy of MBIs to improve health outcomes in patients with 
BD.   
The potential mechanism by which mindfulness could reduce symptoms of 
depression and anxiety might be explained, at least in part, by emotional regulation 
(Aldao et al., 2010) Major emotional regulation strategies related to mindfulness 
include reappraisal, rumination, worry, and non-acceptance (Desrosiers et al., 2013). 
Reappraisal (or reframing) is defined as the attempt to reinterpret an 
emotion-eliciting experience in a way that alters its emotional impact (Gross and 
John, 2003). Practicing mindfulness by taking a nonjudgmental stance toward an 
experience could result in a tendency to adapt a positive reappraisal of a negative 
event, thereby leading to improvements in depression and anxiety symptoms 
(Chambers et al., 2009). In addition, mindfulness may attenuate worry and 
rumination, which are characterized by repetitive thoughts on specifically negative 
emotions, and lead to focus on future threats characteristic of worry, both of which 
are central features of depression and anxiety (Desrosiers et al., 2013). However, 
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more studies are needed to validate these hypotheses. 
In contrast to the changes in depression and anxiety symptoms, we found a 
non-significant treatment effect of MBIs on manic symptoms, even when comparing 
pre- and post-intervention severity scores. Although one article reported that a 
single patient who did not receive MBRP experienced elevated manic symptoms 
according to YMRS score (from 0 at baseline to 6 after the intervention) compared to 
those who did receive MBRP interventions, a definite conclusion cannot be made 
from a single case (Biseul et al., 2016). A ‘floor effect’ could partly explain the lack of 
benefit of MBIs on manic symptoms, because participants with an index (hypo) 
manic episode were excluded from several trials (Bos et al., 2014; Howells et al., 
2014; Miklowitz et al., 2009; Miklowitz et al., 2015; Perich et al., 2013a; Perich et al., 
2013b; Williams et al., 2008). However, in real world clinical practice, it could be 
challenging to engage acute manic participants in MBI-based interventions, because 
MBIs require participants to be fully aware of current experiences. Therefore, MBIs 
could be more suitable for the prevention rather than the treatment of manic 
relapses/recurrence. However, the largest study to date concerning MBIs which 
included patients with BD as adjunctive MBI to TAU versus TAU alone reported no 
difference between treatment groups in the prevention of relapse/recurrence rates 
of either depression or mania/hypomania episodes over a 12-month period (Perich 
et al., 2013b).  
With regards to the secondary outcomes, we did not find that MBIs had 
beneficial effects on cognition based on pre- and post- test analyses. In addition, not 
all of these trials reported baseline cognitive status. Therefore, we cannot make any 
definitive conclusions regarding the role of MBIs on cognition. Nevertheless, our 
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results suggest the potential of MBIs to enhance attention, a sub-domain of 
cognition in patients with BD, and future RCTs are warranted to investigate this issue. 
In addition, MBIs have been shown to improve mindfulness ability (e.g., maintaining 
a non-judgmental and non-reactive stance toward inner experience) as measured by 
the five-facet mindfulness questionnaire (FFMQ), Kentucky inventory of mindfulness 
skills (KIMS), or mindful attention awareness scale (MAAS), and improvements in the 
severity of depressive and anxiety symptoms may be related to greater mindfulness. 
Perich et al. reported that more frequently practicing mindfulness (3 times a week or 
more) resulted in significant improvements in depression and anxiety symptoms 
supporting this hypothesis. Adherence issues should also be evaluated in the future 
studies (Perich et al., 2013a). 
We did not perform subgroup meta-analysis for several secondary outcomes 
due to the lack of evidence available (fewer than three independent studies). 
However, individual studies reported apparently beneficial therapeutic effects for 
MBIs in some domains such as the quality of life (Bos et al., 2014), well-being 
(Deckersbach et al., 2012), emotional regulation (Deckersbach et al., 2012; 
Ives-Deliperi et al., 2013), stress, and rumination (Deckersbach et al., 2012). 
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Limitations 
There are several limitations to this study. First, the included trials had a small 
sample size and often provided no details on randomization procedures. In addition, 
we only enrolled three controlled studies, of which two used a low-quality control 
design (such as a waiting list) (Ives-Deliperi et al., 2013; Williams et al., 2008) and the 
other used a relatively better control design of TAU (applied psychoeducation) 
(Perich et al., 2013b) as the control group. Usually, MBI sessions can persist for 1 to 2 
hours, which greatly increases the time the patients are “taken care of”, resulting in 
moderate effects on their well-being and improvements in depressive and anxiety 
symptoms. As such, future controlled studies with high-quality comparison groups 
are needed. Second, the total number of controlled studies recruited in the current 
meta-analysis was small, precluding the ability to make firm conclusions with 
practical clinical implications. The findings of the present meta-analysis study were 
mainly derived from uncontrolled trials, and the average Jadad score was relatively 
low (1.25 +/- 0.45), which may have influenced the results. Therefore, our findings 
should be interpreted with caution. Third, it is not uncommon to overestimate the 
efficacy of both pharmacotherapy and psychological treatment in clinical trials due to 
publication bias and the selective reporting of ‘positive’ findings (Driessen et al., 
2015; Turner et al., 2008). Even though the interventions were efficacious, they may 
have been less efficacious than the studies would suggest. Fourth, we may have 
missed a number of non-English articles focusing on MBIs. Fifth, we could not rule 
out the possible confounding effects of concurrent psychotropic agents due to 
limited available data. Some psychological treatments for patients with BD may work 
partly by increasing medication adherence or changing life style factors resulting in 
greater regularity (Crowe et al., 2012). In addition, changes in medications may have 
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occurred throughout the trials, and this may have impacted the results. Sixth, the 
high rate of disengaging early from the study in some trials (Biseul et al., 2016; 
Miklowitz et al., 2015) might have contributed to confounding our results. None of 
the recruited studies applied treatment monitoring to alert the therapists of patients 
who were at risk of eventual treatment failure, leading to the high disengagement 
rate. Using adequate treatment monitoring to improve quality control in future RCTs 
is needed (Tasca et al., 2016). 
 
.  
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Conclusion 
The current meta-analysis does not support that MBIs can alleviate depressive and 
anxiety symptoms in patients with BD compared to controls. However, there was 
some tentative evidence of favorable outcomes in the pre- and post-test studies, 
although a non-specific effect cannot be ruled out. Hence, the few (k=3) controlled 
studies did not support the efficacy of MBIs for the treatment of BD. Even though 
MBIs appeared to be a feasible therapeutic option for patients with BD, the 
accessibility of MBIs was not strictly assessed by the present meta-analysis and the 
studies that it included. Currently, it is not justified to use adjunctive MBIs in the 
treatment of bipolar disorder. Future large randomized controlled studies are 
needed to evaluate their effectiveness in various healthcare settings.  
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Figure 1.  Flowchart of the selection strategy and inclusion/exclusion criteria for the 
current meta-analysis. 
Figure 2. (2A) Forest plot showing effect sizes (Hedges’ g) and 95% confidence 
intervals (CIs) from the pooled results of pre- to post- treatment 
comparison of depressive symptoms. (2B) Forest plot showing effect sizes 
(Hedges’ g) and 95% confidence intervals (CIs) from the pooled results of 
pre- to post- treatment comparison of anxiety symptoms. (2C) Forest plot 
showing effect sizes (Hedges’ g) and 95% confidence intervals (CIs) from 
pooled results of pre- to post- treatment comparison of manic symptoms. 
Figure 3. (3A) Experiment-Control comparison of depressive outcome. Figure (3B) 
Experiment-Control comparison of anxiety outcome. 
Figure 4. (4A) Pre- to post- treatment comparison of secondary outcome of 
mindfulness ability. Figure (4B) Pre- to post- treatment comparison of 
secondary outcome of attention. Figure (4C) Pre- to post- treatment 
comparison of secondary outcome of cognition. 
Abbreviation: CI: confidence interval 
 
References 
Aldao, A., Nolen-Hoeksema, S., Schweizer, S., 2010. Emotion-regulation strategies 
across psychopathology: A meta-analytic review. Clin Psychol Rev 30, 217-237. 
Association, A.P., 1994. Diagnostic and Statistical Manual of Mental Disorders. 
Fourth Edition., Fourth Edition ed. American Psychiatric Association, 
Washington, DC. 
Biseul, I., Icick, R., Seguin, P., Bellivier, F., Scott, J., 2016. Feasibility and 
29 
 
Acceptability of the 'HABIT' Group Programme for Comorbid Bipolar and 
Alcohol and Substance use Disorders. Clin Psychol Psychother. 
Bos, E.H., Merea, R., van den Brink, E., Sanderman, R., Bartels-Velthuis, A.A., 2014. 
Mindfulness training in a heterogeneous psychiatric sample: outcome 
evaluation and comparison of different diagnostic groups. J Clin Psychol 70, 
60-71. 
Chambers, R., Gullone, E., Allen, N.B., 2009. Mindful emotion regulation: An 
integrative review. Clin Psychol Rev 29, 560-572. 
Chiesa, A., Serretti, A., 2011. Mindfulness based cognitive therapy for psychiatric 
disorders: a systematic review and meta-analysis. Psychiatry Res 187, 441-453. 
Coelho, H.F., Canter, P.H., Ernst, E., 2007. Mindfulness-based cognitive therapy: 
evaluating current evidence and informing future research. J Consult Clin 
Psychol 75, 1000-1005. 
Crane, C., Barnhofer, T., Duggan, D.S., Hepburn, S., Fennell, M.V., Williams, J.M., 
2008. Mindfulness-Based Cognitive Therapy and Self-Discrepancy in Recovered 
Depressed Patients with a History of Depression and Suicidality. Cognitive 
Therapy and Research 32, 775-787. 
Crowe, M., Porter, R., Inder, M., Lacey, C., Carlyle, D., Wilson, L., 2012. 
Effectiveness of interventions to improve medication adherence in bipolar 
disorder. Aust N Z J Psychiatry 46, 317-326. 
Deckersbach, T., Holzel, B.K., Eisner, L.R., Stange, J.P., Peckham, A.D., Dougherty, 
D.D., Rauch, S.L., Lazar, S., Nierenberg, A.A., 2012. Mindfulness-based cognitive 
therapy for nonremitted patients with bipolar disorder. CNS Neurosci Ther 18, 
133-141. 
Desrosiers, A., Vine, V., Klemanski, D.H., Nolen-Hoeksema, S., 2013. Mindfulness 
and emotion regulation in depression and anxiety: common and distinct 
mechanisms of action. Depress Anxiety 30, 654-661. 
Diseases, I.C.o., International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM). 
Driessen, E., Hollon, S.D., Bockting, C.L., Cuijpers, P., Turner, E.H., 2015. Does 
Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for 
Major Depressive Disorder? A Systematic Review and Meta-Analysis of US 
National Institutes of Health-Funded Trials. PLoS One 10, e0137864. 
Egger, M., Davey Smith, G., Schneider, M., Minder, C., 1997. Bias in meta-analysis 
detected by a simple, graphical test. BMJ 315, 629-634. 
Garland, E.L., Roberts-Lewis, A., Tronnier, C.D., Graves, R., Kelley, K., 2016. 
Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring 
substance dependence, traumatic stress, and psychiatric disorders: Proximal 
30 
 
outcomes from a pragmatic randomized trial. Behav Res Ther 77, 7-16. 
Gotink, R.A., Chu, P., Busschbach, J.J., Benson, H., Fricchione, G.L., Hunink, M.G., 
2015. Standardised mindfulness-based interventions in healthcare: an 
overview of systematic reviews and meta-analyses of RCTs. PLoS One 10, 
e0124344. 
Grande, I., Berk, M., Birmaher, B., Vieta, E., 2016. Bipolar disorder. Lancet 387, 
1561-1572. 
Gross, J.J., John, O.P., 2003. Individual differences in two emotion regulation 
processes: implications for affect, relationships, and well-being. J Pers Soc 
Psychol 85, 348-362. 
Gruber, J., 2011. A review and synthesis of positive emotion and reward 
disturbance in bipolar disorder. Clin Psychol Psychother 18, 356-365. 
Hamilton, K.E., Wershler, J.L., Macrodimitris, S.D., Backs-Dermott, B.J., Ching, L.E., 
Mothersill, K.J., 2012. Exploring the effectiveness of a mixed-diagnosis group 
cognitive behavioral therapy intervention across diverse populations. Cognitive 
and Behavioral Practice 19, 472-482. 
Hedges, L.V., Olkin, I., 1985. Statistical Methods for Meta-Analysis. Academic Press, 
Orlando. 
Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., 2003. Measuring 
inconsistency in meta-analyses. BMJ 327, 557-560. 
Hofmann, S.G., Sawyer, A.T., Witt, A.A., Oh, D., 2010. The effect of 
mindfulness-based therapy on anxiety and depression: A meta-analytic review. 
J Consult Clin Psychol 78, 169-183. 
Howells, F.M., Laurie Rauch, H.G., Ives-Deliperi, V.L., Horn, N.R., Stein, D.J., 2014. 
Mindfulness based cognitive therapy may improve emotional processing in 
bipolar disorder: pilot ERP and HRV study. Metab Brain Dis 29, 367-375. 
Ives-Deliperi, V.L., Howells, F., Stein, D.J., Meintjes, E.M., Horn, N., 2013. The 
effects of mindfulness-based cognitive therapy in patients with bipolar disorder: 
a controlled functional MRI investigation. J Affect Disord 150, 1152-1157. 
Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J., 
McQuay, H.J., 1996. Assessing the quality of reports of randomized clinical trials: 
is blinding necessary? Control Clin Trials 17, 1-12. 
Judd, L.L., Schettler, P.J., Akiskal, H.S., Maser, J., Coryell, W., Solomon, D., Endicott, 
J., Keller, M., 2003. Long-term symptomatic status of bipolar I vs. bipolar II 
disorders. Int J Neuropsychopharmacol 6, 127-137. 
Kabat-Zinn, J., 1990. Full catastrophe living: Using the wisdom of your body and 
mind to face stress, pain and illness, 1st ed. Delacourt, New York. 
Kabat-Zinn, J., 1994. Wherever You Go, There You Are: Mindfulness meditation in 
31 
 
everyday life., 7th ed. Hyperion, New York. 
Kenny, M.A., Williams, J.M., 2007. Treatment-resistant depressed patients show a 
good response to Mindfulness-based Cognitive Therapy. Behav Res Ther 45, 
617-625. 
Khoury, B., Lecomte, T., Fortin, G., Masse, M., Therien, P., Bouchard, V., Chapleau, 
M.A., Paquin, K., Hofmann, S.G., 2013. Mindfulness-based therapy: a 
comprehensive meta-analysis. Clin Psychol Rev 33, 763-771. 
Klainin-Yobas, P., Cho, M.A., Creedy, D., 2012. Efficacy of mindfulness-based 
interventions on depressive symptoms among people with mental disorders: a 
meta-analysis. Int J Nurs Stud 49, 109-121. 
Kuyken, W., Warren, F.C., Taylor, R.S., Whalley, B., Crane, C., Bondolfi, G., Hayes, R., 
Huijbers, M., Ma, H., Schweizer, S., Segal, Z., Speckens, A., Teasdale, J.D., Van 
Heeringen, K., Williams, M., Byford, S., Byng, R., Dalgleish, T., 2016. Efficacy of 
Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An 
Individual Patient Data Meta-analysis From Randomized Trials. JAMA Psychiatry 
73, 565-574. 
Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., 
Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D., 2009. The PRISMA statement 
for reporting systematic reviews and meta-analyses of studies that evaluate 
health care interventions: explanation and elaboration. PLoS Med 6, e1000100. 
Marchand, W.R., 2012. Self-referential thinking, suicide, and function of the 
cortical midline structures and striatum in mood disorders: possible 
implications for treatment studies of mindfulness-based interventions for 
bipolar depression. Depress Res Treat 2012, 246725. 
Mehrmann, C., Karmacharya, R., 2013. Principles and neurobiological correlates of 
concentrative, diffuse, and insight meditation. Harv Rev Psychiatry 21, 205-218. 
Miklowitz, D.J., 2008. Adjunctive psychotherapy for bipolar disorder: state of the 
evidence. Am J Psychiatry 165, 1408-1419. 
Miklowitz, D.J., Alatiq, Y., Goodwin, G.M., Geddes, J.R., Fennell, M.J., 2009. A Pilot 
Study of Mindfulness-Based Cognitive Therapy for Bipolar Disorder. 
International Journal of Cognitive Therapy 2, 373-382. 
Miklowitz, D.J., Semple, R.J., Hauser, M., Elkun, D., Weintraub, M.J., Dimidjian, S., 
2015. Mindfulness-based cognitive therapy for perinatal women with 
depression or bipolar spectrum disorder. Cognitive Therapy and Research. 
Miziou, S., Tsitsipa, E., Moysidou, S., Karavelas, V., Dimelis, D., Polyzoidou, V., 
Fountoulakis, K.N., 2015. Psychosocial treatment and interventions for bipolar 
disorder: a systematic review. Ann Gen Psychiatry 14, 19. 
Murray, G., Leitan, N.D., Berk, M., Thomas, N., Michalak, E., Berk, L., Johnson, S.L., 
32 
 
Jones, S., Perich, T., Allen, N.B., Kyrios, M., 2015. Online mindfulness-based 
intervention for late-stage bipolar disorder: pilot evidence for feasibility and 
effectiveness. J Affect Disord 178, 46-51. 
Opialla, S., Lutz, J., Scherpiet, S., Hittmeyer, A., Jancke, L., Rufer, M., Grosse 
Holtforth, M., Herwig, U., Bruhl, A.B., 2015. Neural circuits of emotion 
regulation: a comparison of mindfulness-based and cognitive reappraisal 
strategies. Eur Arch Psychiatry Clin Neurosci 265, 45-55. 
Oud, M., Mayo-Wilson, E., Braidwood, R., Schulte, P., Jones, S.H., Morriss, R., 
Kupka, R., Cuijpers, P., Kendall, T., 2016. Psychological interventions for adults 
with bipolar disorder: systematic review and meta-analysis. Br J Psychiatry 208, 
213-222. 
Perich, T., Manicavasagar, V., Mitchell, P.B., Ball, J.R., 2013a. The association 
between meditation practice and treatment outcome in Mindfulness-based 
Cognitive Therapy for bipolar disorder. Behav Res Ther 51, 338-343. 
Perich, T., Manicavasagar, V., Mitchell, P.B., Ball, J.R., Hadzi-Pavlovic, D., 2013b. A 
randomized controlled trial of mindfulness-based cognitive therapy for bipolar 
disorder. Acta Psychiatr Scand 127, 333-343. 
Perlis, R.H., Ostacher, M.J., Patel, J.K., Marangell, L.B., Zhang, H., Wisniewski, S.R., 
Ketter, T.A., Miklowitz, D.J., Otto, M.W., Gyulai, L., Reilly-Harrington, N.A., 
Nierenberg, A.A., Sachs, G.S., Thase, M.E., 2006. Predictors of recurrence in 
bipolar disorder: primary outcomes from the Systematic Treatment 
Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 163, 
217-224. 
Piet, J., Hougaard, E., 2011. The effect of mindfulness-based cognitive therapy for 
prevention of relapse in recurrent major depressive disorder: a systematic 
review and meta-analysis. Clin Psychol Rev 31, 1032-1040. 
Ramel, W., Goldin, P.R., Carmona, P.E., McQuaid, J.R., 2004. The effects of 
mindfulness meditation on cognitive processes and affect in patients with past 
depression. Cognitive Therapy and Research 28, 433-455. 
Sipe, W.E., Eisendrath, S.J., 2012. Mindfulness-based cognitive therapy: theory 
and practice. Can J Psychiatry 57, 63-69. 
Stange, J.P., Eisner, L.R., Holzel, B.K., Peckham, A.D., Dougherty, D.D., Rauch, S.L., 
Nierenberg, A.A., Lazar, S., Deckersbach, T., 2011. Mindfulness-based cognitive 
therapy for bipolar disorder: effects on cognitive functioning. J Psychiatr Pract 
17, 410-419. 
Strauss, C., Cavanagh, K., Oliver, A., Pettman, D., 2014. Mindfulness-based 
interventions for people diagnosed with a current episode of an anxiety or 
depressive disorder: a meta-analysis of randomised controlled trials. PLoS One 
33 
 
9, e96110. 
Stubbs, B., Vancampfort, D., Solmi, M., Veronese, N., Fornaro, M., 2016. How 
common is bipolar disorder in general primary care attendees? A systematic 
review and meta-analysis investigating prevalence determined according to 
structured clinical assessments. Aust N Z J Psychiatry 50, 631-639. 
Tasca, G.A., Cabrera, C., Kristjansson, E., MacNair-Semands, R., Joyce, A.S., 
Ogrodniczuk, J.S., 2016. The therapeutic factor inventory-8: Using item 
response theory to create a brief scale for continuous process monitoring for 
group psychotherapy. Psychother Res 26, 131-145. 
Teasdale, J.D., Segal, Z., Williams, J.M., 1995. How does cognitive therapy prevent 
depressive relapse and why should attentional control (mindfulness) training 
help? Behav Res Ther 33, 25-39. 
Teasdale, J.D., Segal, Z.V., Williams, J.M., Ridgeway, V.A., Soulsby, J.M., Lau, M.A., 
2000. Prevention of relapse/recurrence in major depression by 
mindfulness-based cognitive therapy. J Consult Clin Psychol 68, 615-623. 
Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A., Rosenthal, R., 2008. 
Selective publication of antidepressant trials and its influence on apparent 
efficacy. N Engl J Med 358, 252-260. 
Van Dijk, S., Jeffrey, J., Katz, M.R., 2013. A randomized, controlled, pilot study of 
dialectical behavior therapy skills in a psychoeducational group for individuals 
with bipolar disorder. J Affect Disord 145, 386-393. 
Weber, B., Jermann, F., Gex-Fabry, M., Nallet, A., Bondolfi, G., Aubry, J.M., 2010. 
Mindfulness-based cognitive therapy for bipolar disorder: a feasibility trial. Eur 
Psychiatry 25, 334-337. 
Williams, J.M., Alatiq, Y., Crane, C., Barnhofer, T., Fennell, M.J., Duggan, D.S., 
Hepburn, S., Goodwin, G.M., 2008. Mindfulness-based Cognitive Therapy 
(MBCT) in bipolar disorder: preliminary evaluation of immediate effects on 
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Table 1: summarization of recruited studies in current 
meta-analysis 
Author 
(year) 
Criteria 
(Psychiatry
) 
Diagn
osis 
Comp
arison 
Subj
ects 
Mean 
age 
Femal
e (%) 
Pre-Tx 
mood 
severity
1 
Post-Tx 
mood 
severity
1 
Drop-out 
rate (%) 
countr
y 
34 
 
Biseul, I. 
(2016) 
DSM-IV BD 
Subst
ance 
Pre-po
st Tx 
5 48.9 40.0 (MADRS) 
7.7±6.2 
(YMRS) 
0.3±0.8 
(MADRS) 
4.5±2.3 
(YMRS) 
1.2±1.3 
8.2 France 
Miklowitz
, D. J. 
(2015) 
DSM-IV Perin
atal 
wom
en 
with 
BD 
Pre-po
st Tx 
12 33.7 100.0 (BDI-II) 
7.7±8.9 
(HAMD) 
3.14±2.34 
(YMRS) 
4.1±4.1 
(STAI) 
43.8±4.8 
(FFMQ) 
132.5±19.1 
n/a 41.7 USA 
Bos, E. H. 
(2014) 
DSM-IV BD Pre-po
st Tx 
42 45.5 69.2 n/a n/a n/a Nethe
rlands 
Howells, 
F. M. 
(2014) 
DSM-IV BD Pre-po
st Tx 
12 37.0 77.8 *(YMRS) 
3.4±3.0  
(HADS-A) 
8.4±4.5 
(HADS-D) 
5.1±2.9 
(HADS-A) 
7.8±3.5 
(HADS-D) 
5.8±4.8 
0.0 South 
Africa 
Ives-Delip
eri, V. L. 
(2013) 
DSM-IV BD MBI + 
TAU  
TAU 
(waiti
ng list) 
16 
7 
37.6 60.0 (HADS-D) 
5.8±4.2 
6.0±4.8  
(BAI) 
19.8±12.7 
23.0±9.4 
(HADS-D) 
4.0±3.1 
6.4±4.8 
(BAI) 
14.1±12.1 
20.6±9.9 
0.0 South 
Africa 
Perich, T. 
(2013) 
a, #
 
DSM-IV BD MBI + 
TAU 
TAU 
48                                          
47 
n/a 65.0
66.0 
(MADRS) 
11.2±8.2 
14.6±10.9 
(YMRS) 
5.0±4.5 
5.5±4.4  
(DASS-D) 
14.8±12.1 
19.5±14.2 
(DASS-A) 
(MADRS)
7.1±7.3 
11.1±9.3 
(YMRS) 
4.0±4.6 
4.4±4.4 
(DASS-D) 
13.7±11.9 
15.7±14.7 
(DASS-A) 
37.9 Austra
lia 
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11.9±10.4 
12.9±11.2 
9.7±9.5 
5.4±9.1 
Perich, T. 
(2013)
 b, #
 
DSM-IV BD Pre-po
st Tx 
23 42.0 69.0 (MADRS) 
11.1±8.2 
(YMRS) 
4.8±3.7  
(DASS-D) 
14.4±11.9 
(DASS-A) 
12.2±10.7 
(MADRS) 
8.8±7.3 
(YMRS) 
4.5±4.8 
(DASS-D) 
12.2±8.7 
(DASS-A) 
8.8±6.7 
n/a Austra
lia 
Deckersb
ach, T. 
(2012) 
DSM-IV BD Pre-po
st Tx 
12 38.7 80.0 (HAMD) 
11.8±7.2  
(YMRS) 
5.4±5.1 
(HAMD) 
6.3±7.6 
(YMRS) 
4.7±7.1 
16.7 USA 
Stange, J. 
P. 
(2011) 
DSM-IV BD Pre-po
st Tx 
8 41.9 75.0 n/a n/a 10.0 USA 
Weber, B. 
(2010) 
DSM-IV BD Pre-po
st Tx 
15 48.0 
(media
n) 
73.3 (YMRS) 1 
(median)  
(BDI-II) 10 
(median) 
*(YMRS) 1 
(median)  
*(BDI-II) 15 
(median) 
34.8 Switze
rland 
Miklowitz
, D.J. 
(2009) 
DSM-IV BD Pre-po
st Tx 
22 40.6 72.7 (YMRS) 
2.1±2.9 
(BDI) 
15.6±12.1 
(BAI) 
15.4±11.4 
(YMRS) 
1.8±1.7 
(BDI) 
10.6±7.5 
(BAI) 
12.8±10.9 
27.3 UK 
Williams, 
J. M. 
(2008) 
DSM-IV BD MBI + 
TAU  
TAU 
(waiti
ng list) 
7                                          
7 
36.9
46.8 
71.4
28.6 
(BAI)
12.7±12.1 
11.4±8.5 
(BDI) 
15.8±14.4 
12.8±8.1 
(BAI) 6.8±5.7 
20.6±11.3 
(BDI) 7.1±7.7 
15.3±8.1 
n/a UK 
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#: from same population but different study design. 
*: derive effect size from other statistical data. 
1: as the choice of specific scales for mood severity, we preferred (1) BDI, followed by 
DASS, MADRS and HAM-D for depressive severity, (2) BAI, followed by DASS and STAI 
for anxiety severity, and (3) YMRS for manic severity because the most studies using 
BDI, BAI, and YMRS for depressive, anxiety, and manic severity. 
Abbreviation: BAI: Beck anxiety index; BD: bipolar disorder; BDI: Beck depression 
inventory; CPAS: clinical positive affective scale; DASS: depression anxiety stress 
scales; DSM-IV: diagnostic and statistical manual of mental disorders, 4th edition; 
FFMQ: five-facet mindfulness questionnaire; HADS: hospital anxiety and depression 
scale; HAMD: Hamilton depressive scale; MADRS: Montgomery–Åsberg depression 
rating scale; MBI: mindfulness-based intervention; n/a: not available; Pre-post Tx: 
comparison of disease severity before and after treatment; STAI: state-trait anxiety 
inventory; TAU: treatment as usual; Tx: treatment; YMRS: Young mania rating scale 
a. Perich, T., Manicavasagar, V., Mitchell, P.B., Ball, J.R., Hadzi-Pavlovic, D., 2013b. A 
randomized controlled trial of mindfulness-based cognitive therapy for bipolar 
disorder. Acta Psychiatr Scand 127, 333-343. 
b. Perich, T., Manicavasagar, V., Mitchell, P.B., Ball, J.R., 2013a. The association 
between meditation practice and treatment outcome in Mindfulness-based 
Cognitive Therapy for bipolar disorder. Behav Res Ther 51, 338-343. 
Table 2: Summary and comparison of different findings of 
meta-analyses by other studies 
Article Interven
tion 
Diagnosis Studi
es 
(N) 
Primary 
outcome 
Secondary Side 
effect 
Drop 
out 
Chu CS 
(2017) 
(current 
MA) 
MBIs 
(MBCT: 
10 
MBSR: 1 
MT: 1) 
BD 12 Pre MBIs vs 
post MBIs: 
More 
reduced 
symptoms 
of: 
Depression 
(Hedges’ g: 
0.58, 95% 
CI: 0.31 to 
0.84) 
Pre MBIs vs post 
MBIs: 
More benefit in: 
Mindfulness ability 
(Hedges’ g: 0.49, 
95% CI: 0.12 to 0.85) 
Attention (Hedges’ 
g: 0.61, 95% CI: 0.19 
to 1.03) 
But not in cognition 
(Hedges’ g: 0.35, 
n/a 25.7 
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Anxiety 
(Hedges’ g: 
0.34, 95% 
CI: 0.01 to 
0.67) 
But Not 
Mania 
(Hedges’ g: 
0.09, 95% 
CI: -0.16 to 
0.33) 
MBIs + TAU 
vs TAU: 
No reduced 
symptoms 
of 
Depression 
(Hedges’ g: 
0.46, 95% 
CI: -0.44 to 
1.35) 
Anxiety 
(Hedges’ g: 
0.33, 95% 
CI: -0.84 to 
1.50) 
Mania (only 
one study 
enrolled) 
95% CI: -0.15 to 
0.84) 
MBIs + TAU vs TAU: 
Not performed due 
to limited data 
available (Less than 
3 articles in each 
secondary 
outcomes) 
MA by 
Kuyken 
W 
(2016)
 a
 
MBCT Recurrent 
MDD 
9 Reduced 
risk of 
depressive 
60-weeks 
relapse 
MBCT vs 
No-MBCT 
(HR: 0.69; 
95% CI: 0.58 
n/a 10 SAE 
in 
MBCT 
16 SAE 
in 
non-M
BCT 
n/a 
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to 0.82) 
MBCT vs 
active 
treatment 
(HR: 0.79; 
95% CI: 0.64 
to 0.97) 
MBCT vs 
antidepress
ants (HR: 
0.77; 95% 
CI: 0.60 to 
0.98) 
MA by 
Gotink 
RA 
(2015)
 b
 
MBIs 
(MBSR, 
MBCT) 
Physical/m
ental 
diseases 
115 MBSR and 
MBCT vs 
wait-list/TA
U: More 
reduced 
symptoms 
of: 
Depression 
(SMD=-0.37
;95% CI: 
-0.45 to 
-0.28) 
Anxiety 
(SMD=-0.48
;95% CI: 
-0.56 to 
-0.40) 
MBSR and MBCT vs 
wait-list/TAU: More 
reduced symptoms 
of: 
Stress(SMD=-0.51;9
5% CI: -0.67 to 
-0.36) 
Quality of 
life(SMD=-0.39;95% 
CI: -0.70 to -0.08) 
Physical 
functioning(SMD=-0.
27;95% CI: -0.42 to 
-0.12) 
n/a n/a 
MA by 
Strauss C 
(2014)
 c
 
MBIs 
(MBSR, 
MBCT, 
PBCT) 
Depression 
Anxiety 
disorder 
12 MBIs vs 
control: 
More 
reduced 
symptoms 
of: 
Depression 
(SMD= 
n/a n/a (medi
an) 
15.5 
39 
 
-0.73; 
95%CI: 
-1.36 to 
-0.09) 
But Not for 
anxiety 
(SMD=-0.55
; 95% CI: 
-1.18 to 
0.09) 
MA by 
Klainin-Y
obas P 
(2012)
 d
 
MBIs 
(MBSR, 
MBCT, 
ABT, 
DBT, 
MAGT 
etc.) 
Mental 
disorder 
39 MBIs vs 
TAU: More 
reduced 
symptoms 
of: 
Depression 
(SMD=0.53;
95% CI: 0.39 
to 0.67) 
n/a n/a n/a 
MA by 
Chiesa A 
(2011)
 e
 
MBCT Mental 
disorders 
16 MBCT+TAU 
vs TAU: 
Relapse 
Prevention 
(OR: 0.30; 
95% CI: 0.17 
to 0.56) 
Reduced 
depress 
(SMD: 
-10.3; 95% 
CI: -17.2 to 
-3.41) in 
Depressive 
disorder 
Reduced 
anxiety 
(SMD: 
-13.8; 95% 
n/a n/a n/a 
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CI: -23.2 to 
-4.42) in 
patient with 
BD 
MA by 
Piet J 
(2011)
 f
 
MBCT Recurrent 
MDD 
6 Reduced 
risk of 
depression 
relapse 
MBCT vs 
TAU/placeb
o (RR: 0.66; 
95% CI: 0.53 
to 0.82) 
n/a n/a 16.2 
MA by 
Hofmann 
SG 
(2010)
 g
 
MBIs 
(MBCT, 
MBSR, 
MT, etc.) 
Anxiety 
and 
depress in 
physical/m
ental 
disease 
44 Pre MBIs vs 
post MBIs: 
Reduced 
anxiety in 
various 
diseases 
(Hedges’ g = 
0.63, 95% 
CI: 0.53 to 
0.73) 
Reduced 
depress in 
various 
diseases 
(Hedges’ g = 
0.59, 95% 
CI: 0.51 to 
0.66). 
n/a n/a n/a 
Abbreviation: ABT: Acceptance-based behavioural therapy; CBT: Cognitive behavioural therapy; CI: 
confidence interval; DBT: dialectical behaviour therapy for depression; HR: hazard ratio; MA: 
meta-analysis; MAGT: Mindfulness and Acceptance-based group therapy; MBCT: mindfulness-based 
cognitive therapy; MBI: mindfulness-based intervention; MBSR: mindfulness-based stress reduction; 
MDD: major depressive disorder; MT: mindfulness training; n/a: not available; PBCT : Person-based 
cognitive therapy; RR: risk ratio; SAE: severe adverse event; SAR: severe adverse reaction; SMD: 
standardized mean difference; TAU: treatment as usual 
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a. Kuyken W, Warren FC, Taylor RS, et al. Efficacy of Mindfulness-Based Cognitive Therapy in 
Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized 
Trials. JAMA psychiatry 2016;73(6):565-74. doi: 10.1001/jamapsychiatry.2016.0076 
b. Gotink RA, Chu P, Busschbach JJ, et al. Standardised mindfulness-based interventions in healthcare: 
an overview of systematic reviews and meta-analyses of RCTs. PloS one 2015;10(4):e0124344. doi: 
10.1371/journal.pone.0124344 
c. Strauss C, Cavanagh K, Oliver A, et al. Mindfulness-based interventions for people diagnosed with a 
current episode of an anxiety or depressive disorder: a meta-analysis of randomised controlled 
trials. PloS one 2014;9(4):e96110. doi: 10.1371/journal.pone.0096110 
d. Klainin-Yobas P, Cho MA, Creedy D. Efficacy of mindfulness-based interventions on depressive 
symptoms among people with mental disorders: a meta-analysis. International journal of nursing 
studies 2012;49(1):109-21. doi: 10.1016/j.ijnurstu.2011.08.014 
e. Chiesa A, Serretti A. Mindfulness based cognitive therapy for psychiatric disorders: a systematic 
review and meta-analysis. Psychiatry research 2011;187(3):441-53. doi: 
10.1016/j.psychres.2010.08.011 
f. Piet J, Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in 
recurrent major depressive disorder: a systematic review and meta-analysis. Clinical psychology 
review 2011;31(6):1032-40. doi: 10.1016/j.cpr.2011.05.002 
g. Hofmann SG, Sawyer AT, Witt AA, et al. The effect of mindfulness-based therapy on anxiety and 
depression: A meta-analytic review. Journal of consulting and clinical psychology 
2010;78(2):169-83. doi: 10.1037/a0018555 
Highlight: 
1. Mindfulness-based interventions (MBIs) have shown promise in improving health 
outcomes in patients with various psychiatric conditions; however, their effect in 
bipolar disorder is unclear.   
2. In pre- and post-test analyses, MBIs appeared to reduce depressive symptoms, the 
severity of anxiety, and improve attention, although a non-specific effect may have 
accounted for these results. 
3. Compared to controls, MBIs did not reduce depression, anxiety, or mania, 
although available evidence was limited to only a few studies. 
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Potential studies identified through database search: 
Database: PubMed (n=54), ScienceDirect (n=589), EBSCOhost-Medline (n=53), Psychology and Behavior 
Sciences Collection (n=18), Cochrane library (n=18), and ClinicalTrials.gov (n=17). 
Keyword: (meditation OR mindfulness) AND (bipolar disorder OR bipolar)
Date: date available to Nov 28th , 2016 (n=750)
Potential studies identified through published reference lists: n=6
Titles and abstracts screened after removing duplicates (n= 675)
Excluded as not relevant articles (n=503)
Potential studies retrieved for assessment of eligibility (n=172)
Studies excluded: n=160
Meta-analysis n=6
Review/comment  n=37
Non-relevant diagnosis n=55 (mixed-diagnosis included 
small numbers patients with bipolar disorder, n =5)
Not-MBIs trials n=33
Atypical MBIs trials n=20 (DBT=11, ACT=8, on-line MBIs=1)
Poor design n=7 (Qualitative study=1, Cross-sectional 
study=1, study protocol=3, Case report/series n=2)
No detail data available n=1
Same study population n=1
Included articles in meta-analysis
(n=12)
Figure 1 Search strategy and selection criteria of current study  
 
Study name Statistics for each study Weight Hedges's g and 95% CI
Hedges's Lower Upper Relative 
g limit limit
p-Value
weight
Biseul, I. (2016) 0.618 -0.534 1.770 0.293 5.35
Miklowitz, D.J. (2015) 0.959 0.141 1.778 0.022 10.58
Howells, F. M. (2013) 0.183 -0.591 0.958 0.643 11.83
Perich, T. (2013) 0.206 -0.376 0.788 0.488 20.95
Deckrsbach, T. (2012) 0.717 -0.082 1.516 0.079 11.12
Miklowitz, D.J. (2009) 0.487 -0.103 1.076 0.106 20.44
Overall
1.011 0.411 1.611 0.001
100.000.578 0.312 0.844 0.000
-2.00 -1.00 0.00 1.00 2.00
Favors worse 
after MBIs
Favors improved 
after MBIs
Weber, B. (2010) 19.72
Figure 2A Pre- to post- treatment comparison of depressive symptoms  
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Study name Statistics for each study Weight Hedges's g and 95% CI
Hedges's Lower Upper Relative 
g limit limit
p-Value
weight
Ives-Deliperi, V. L. (2013) 0.578 -0.294 1.450 0.194 31.61
Perich, T. (2013) -0.198 -0.598 0.202 0.333 41.52
Overall
1.327 0.230 2.424 0.018
100.000.457 -0.435 1.349 0.315
-2.00 -1.00 0.00 1.00 2.00
Favors poorer 
by MBIs
Favors better 
by MBIs
Williams, J.M.G. (2008) 26.88
Figure 3A Experiment-Control comparison of depressive outcome
 
 
Study name Statistics for each study Weight Hedges's g and 95% CI
Hedges's Lower Upper Relative 
g limit limit
p-Value
weight
Bos, E. H. (2014) 0.525 -0.184 1.234 0.146 17.57
Perich, T. (2013) 0.543 -0.036 1.122 0.066 22.61
Deckrsbach, T. (2012) 0.593 -0.198 1.383 0.142 15.11
Weber, B. (2010) 0.000 -0.478 0.478 1.000 27.64
Overall
1.068 0.344 1.793 0.004
100.000.487 0.124 0.850 0.009
-2.00 -1.00 0.00 1.00 2.00
Favors poorer after MBIs Favors better after MBIs
Lves-Deliperi, V. L. (2013) 17.07
Figure 4A Pre- to post- treatment comparison of secondary outcome of mindfulness ability
 
 
 
